REFERENCES BIBLIOGRAPHIQUES
63
 Baya, A. M., P. R. Brayton, V. L. Brown, D. J. Grimes, E. Russek-Cohen, et R. R.
Colwell. 1986. Coincident Plasmids and Antimicrobial Resistance in Marine Bacteria
Isolated From Polluted and Unpolluted Atlantic Ocean Samples. Applied and
Environmental Microbiology. 51(6): 1285-1292.
 Berche, P., L. Gaillard, et M. Simonet. 1988. Bactériologie, Les bactéries des infections
humaines, 1
ére édition. Ed. Flammarion. Paris, France. p230-590.
 Berthelot, P., F. Grattard, F. O. Mallaval, A. Ros, F. Lucht, et B. Pozzetto. 2005.
Épidémiologie des infections nosocomiales à Pseudomonas aeruginosa, Burkholderia
cepacia et Stenotrophomonas maltophilia. Pathologie Biologie. 53 : 341-348.
 Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M
enzymes. Antimicrobial Agents and Chemotherapy. 48 : 1-14.
 Bouhaddioui, B., K. Ben Slama, S. Gharbi, et A. Boudabous. 2002. Epidemiology of
clinical and environmental Pseudomonas aeruginosa strains. Ann. Microbiol. 52: 223235.
 Bradford, A. P. 2001. Extended-Spectrum β-lactamases in the 21
st Century:
Caracterisation, Epidemiology, and Detection of this important Resistance Threat.
Clinical Microbiology Revue. 14: 933-951.
 Brayan, A., N. Shapir, et M. J. Sadowsky. 2004. Frequency and distribution of
tetracycline resistance genes in genetically diverse, non selected and non clinical
Escherichia coli strains isolated from diverse human and animal sources. Applied
Environmental Microbiology .70: 2503 - 2507.
 Brigante, G., F. Luzzaroa, M. Perilli, G. Lombardi, A. Coli, G. M. Rossolini, G.
Amicosante, et A. Toniolo. 2005. Evolution of CTX-M-type β-lactamase in isolates of
Escherichia coli infecting hospital and community patients. International Journal of
Antimicrobial Agents. 25: 157-162.
 Bryskier, A. 1999. Antibiotiques, agents antibactériens et antifongiques. Ed, Ellipses.
Paris, France. P 1216.
 Busch, K. 1989. Classification of β-lactamases: groups 1, 2a, 2b, and 2b’ In Palzkill T.,
1992. Identification of amino Acid Substitution That Alter the Substrate Specifity of
TEM-1 β-lactamases. Journal of Bacteriology. 174: 5237-5243.
 Busch, K., G. A. Jachoby, et A. A. Medeiros. 1995. A fonctional classification scheme
for β-lactamases and its correlation with molecular structure. Antimicrobial Agent and
Chemotherapy. 39: 1211-1233.
 Bush K. 1988. Recent developments in β-lactamases research and their implications for
the future. Rev. Infect. Dis. 10: 681–690; 739–743.
 Bush, K., et G. A. Jacoby. 2010. Updated Functional Classification of β-lactamases.
Antimicrobial Agents and Chemotherapy. 54: 969-976.
 Bush, K., et R. B. Sykes. 1987. Characterization and epidemiology of β-lactamases.
Elsevier Science Publishers BV, Philadelphia, PA.